Meridian Bioscience - 28 Year Stock Price History | VIVO

Historical daily share price chart and data for Meridian Bioscience since 1992 adjusted for splits. The latest closing stock price for Meridian Bioscience as of September 24, 2020 is 15.51.
  • The all-time high Meridian Bioscience stock closing price was 35.90 on April 08, 2008.
  • The Meridian Bioscience 52-week high stock price is 26.58, which is 71.4% above the current share price.
  • The Meridian Bioscience 52-week low stock price is 5.51, which is 64.5% below the current share price.
  • The average Meridian Bioscience stock price for the last 52 weeks is 12.87.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Meridian Bioscience Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 14.1161 9.6100 26.4100 5.5700 15.5100 58.75%
2019 12.0993 16.8500 17.6100 7.9000 9.7700 -43.72%
2018 15.5723 14.4000 19.7200 13.8000 17.3600 24.00%
2017 14.3300 17.8500 17.8500 12.2000 14.0000 -20.90%
2016 19.1122 19.5200 21.3600 15.9000 17.7000 -13.74%
2015 18.6224 16.3800 21.0000 16.3800 20.5200 24.67%
2014 20.0323 26.1100 27.2400 15.9200 16.4600 -37.96%
2013 22.7707 20.7600 26.6000 19.5200 26.5300 31.01%
2012 18.9799 19.0700 20.7900 16.3000 20.2500 7.48%
2011 20.9888 23.6400 27.3200 14.9000 18.8400 -18.65%
2010 20.4669 21.6500 24.2000 16.3100 23.1600 7.47%
2009 21.3360 26.1600 26.1600 15.4300 21.5500 -15.39%
2008 28.3179 29.8100 35.9000 19.5500 25.4700 -15.33%
2007 23.8903 16.5333 34.0900 16.4333 30.0800 83.94%
2006 15.7730 14.7000 18.3667 13.0000 16.3533 21.80%
2005 10.0565 7.8933 15.2667 6.0711 13.4267 72.14%
2004 5.4219 4.6533 8.2444 4.4089 7.8000 68.10%
2003 4.1528 3.1111 5.0978 3.0449 4.6400 51.74%
2002 2.8727 2.7778 3.3733 2.1956 3.0578 14.23%
2001 2.0895 2.2222 2.9244 1.0280 2.6769 21.97%
2000 3.2559 3.2222 4.8622 2.1111 2.1947 -31.89%
1999 3.2073 3.0000 3.8058 2.6667 3.2222 7.41%
1998 4.2167 4.5556 6.4711 2.2222 3.0000 -33.37%
1997 4.4871 5.5556 6.0578 2.5556 4.5022 -22.08%
1996 5.1986 5.0000 6.8044 3.9467 5.7778 15.56%
1995 3.3178 2.0741 5.2222 2.0741 5.0000 141.07%
1994 2.4546 2.5926 3.2593 1.9259 2.0741 -20.00%
1993 2.8490 2.6667 3.4815 2.2963 2.5926 -2.78%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.715B $0.201B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $181.887B 34.13
Medtronic (MDT) Ireland $138.427B 26.07
Stryker (SYK) United States $75.865B 29.42
Boston Scientific (BSX) United States $53.965B 31.17
Lonza Group Ag (LZAGY) Switzerland $46.014B 0.00
Baxter (BAX) United States $39.653B 24.25
Terumo (TRUMY) Japan $30.123B 38.51
Zimmer Biomet Holdings (ZBH) United States $27.691B 22.98
EssilorLuxottica Societe Anonyme (ESLOY) France $26.945B 0.00
ResMed (RMD) United States $24.445B 35.44
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.497B 0.00
Bio-Rad Laboratories (BIO) United States $15.189B 68.69
Insulet (PODD) United States $14.945B 632.36
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.231B 43.60
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.192B 10.63
Hill-Rom Holdings (HRC) United States $5.491B 13.63
Canopy Growth (CGC) Canada $5.428B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.362B 0.00
Haemonetics (HAE) United States $4.233B 28.21
Neogen (NEOG) United States $3.961B 64.96
ICU Medical (ICUI) United States $3.885B 29.64
Envista Holdings (NVST) United States $3.637B 24.80
TG Therapeutics (TGTX) United States $3.131B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.105B 0.00
Abcam (ABCZY) $3.102B 0.00
National Vision Holdings (EYE) United States $3.026B 470.38
NuVasive (NUVA) United States $2.513B 35.03
Agios Pharmaceuticals (AGIO) United States $2.442B 0.00
AtriCure (ATRC) United States $1.731B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.686B 153.85
NanoString Technologies (NSTG) United States $1.657B 0.00
Cardiovascular Systems (CSII) United States $1.417B 0.00
MacroGenics (MGNX) United States $1.338B 0.00
Aphria (APHA) Canada $1.282B 0.00
InMode (INMD) Israel $1.134B 28.60
Cerus (CERS) United States $0.979B 0.00
Quanterix (QTRX) United States $0.932B 0.00
Owens & Minor (OMI) United States $0.880B 19.70
BioLife Solutions (BLFS) United States $0.870B 453.00
PetIQ (PETQ) United States $0.853B 24.48
OraSure Technologies (OSUR) United States $0.831B 0.00
Lantheus Holdings (LNTH) United States $0.800B 11.09
Phibro Animal Health (PAHC) United States $0.712B 16.30
LeMaitre Vascular (LMAT) United States $0.677B 41.30
Vapotherm (VAPO) United States $0.661B 0.00
Aurora Cannabis (ACB) Canada $0.597B 0.00
Zynex (ZYXI) United States $0.579B 50.58
Omeros (OMER) United States $0.558B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.538B 76.04
Surmodics (SRDX) United States $0.524B 57.52
VAREX IMAGING (VREX) United States $0.463B 20.07
Cytosorbents (CTSO) United States $0.336B 0.00
Viemed Healthcare (VMD) United States $0.325B 11.62
HEXO (HEXO) $0.323B 0.00
Utah Medical Products (UTMD) United States $0.285B 24.48
InfuSystems Holdings (INFU) United States $0.259B 49.35
Neptune Wellness Solutions (NEPT) Canada $0.243B 0.00
Surface Oncology (SURF) United States $0.241B 0.00
Organigram Holdings (OGI) Canada $0.216B 0.00
Chimerix (CMRX) United States $0.187B 0.00
Female Health (VERU) United States $0.187B 0.00
Wound Management Technologies (SMTI) United States $0.163B 0.00
Bovie Medical (APYX) United States $0.150B 0.00
Fonar (FONR) United States $0.144B 12.79
Exagen (XGN) United States $0.138B 0.00
Liberty Health Sciences (LHSIF) United States $0.133B 0.00
Evolus (EOLS) United States $0.126B 0.00
Capricor Therapeutics (CAPR) United States $0.101B 0.00
Chembio Diagnostics (CEMI) United States $0.088B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.087B 0.00
Rockwell Medical (RMTI) United States $0.084B 0.00
United-Guardian (UG) United States $0.068B 15.35
Oramed Pharmaceuticals (ORMP) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.063B 0.00
MTech Acquisition (KERN) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 0.00
Trinity Biotech (TRIB) Ireland $0.049B 9.27
ImmuCell (ICCC) United States $0.038B 0.00
FSD PHARMA INC (HUGE) Canada $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.020B 0.00
Akers Biosciences Inc (AKER) United States $0.020B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.018B 0.00
NF Energy Saving (BIMI) China $0.017B 0.00
Myomo (MYO) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00